Review

chir99021 (MedChemExpress)

MedChemExpress is a verified supplier

MedChemExpress manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

MedChemExpress chir99021
Chir99021, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 448 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chir99021/Laduviglusib/bio_rxiv__64898__2026__07__31__742169-217-70-71
Average 99 stars, based on 448 article reviews

chir99021 - by Bioz Stars, 2026-09

99/100 stars

Images

other:

Article Title: Establishment of a broiler jejunal organoid model based on optimized activators or optimized two-step media and its assessment
Article Snippet: The components of JOGM were identical to CMDM, and the components of JODM contained 97% ( v / v ) Advanced DMEM/F12, 1% ( v / v ) P/S, 1% ( v / v ) Glutamax, 1% ( v / v ) HEPES, 1 mM NAC, 10 μM Y-27632 2HCl, 10 μM SB202190, 0.5 μM A83-01, 50 ng/mL EGF, 50 ng/mL RSPO1 (RC010070C, XianJue Biotechnology, Suzhou, China), 50 ng/mL Noggin (RC010100C, XianJue Biotechnology, Suzhou, China), and 2.5 μM CHIR99021 (HY-10182, MCE, NJ, USA).

Passaging:

Article Title: Derivation of Equine Mesenchymal Stem/Stromal Cells from Induced Pluripotent Stem Cells via the Neural Crest Pathway and Characterisation by Immunophenotype and Tri-Lineage Differentiation.
Article Snippet: .. For eqiNCCs induction, the culture media were directly exchanged (without previously passaging the cells or removing the iMEFs) for iNCC induction media, consisting of a 1:1 mix of Iscove’s Modified Dulbecco’s Medium (IMDM) and Ham’s F12 Nutrient (GibcoTM, Thermo Fisher), and supplemented with 1% chemically defined lipid concentrate (CDLC; GibcoTM, Thermo Fisher), 1% insulin–transferrin–selenium premix (ITS+ premix; GibcoTM, Thermo Fisher), 450 μM 1-thioglycerol (Sigma–Aldrich), 100 U/mL penicillin, 100 μg/mL streptomycin, 10 μM SB431542 and 1 μM CHIR99021 (Quimigen, MedChemExpress) for 10 days. ..

Modification:

Knock-Out:

Article Title: The Fontan EV Score: A Circulating Extracellular Vesicle-Based Risk Stratification Tool for Fontan-Associated Liver Disease
Article Snippet: .. Day 1: RPMI supplemented with 50 ng/ml BMP4 and 100 ng/ml Activin A; Day 2: RPMI with100 ng/ml Activin A and 0.2% Knockout serum replacement (KSR, Gibco, Cat# A3181502); Day 3: RPMI containing 100 ng/ml Activin A and 2% KSR; Day 4-6: Advanced DMEM/F12 (Gibco, Cat# 12634) containing 1x B27 (Gibco, Cat# 17504), 1xN2 (Gibco, Cat# 17502), 500ng/mL recombinant human fibroblast growth factor-4 (FGF-4, SinoBiological, Cat# 16043-HNAE), and 3 μM CHIR99021 (MedChemExpress, Cat# HY-10182). ..

Recombinant:

Image Search Results

A schematic showing BMP4-mediated osteogenesis maturation through CHIR-induced mesodermal differentiation through Wnt activation and BMP signaling, efficient osteoblast differentiation with hiPSCs is synergistically promoted through Wnt/BMP signaling. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP4, Bone morphogenetic protein 4.

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: A schematic showing BMP4-mediated osteogenesis maturation through CHIR-induced mesodermal differentiation through Wnt activation and BMP signaling, efficient osteoblast differentiation with hiPSCs is synergistically promoted through Wnt/BMP signaling. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP4, Bone morphogenetic protein 4.

Article Snippet: The medium consisted of STEMdiffTM APELTM2 Medium (APEL; 05270, STEMCELL, Canada) supplemented with 6 ng/mL StemMACS CHIR99021 (CHIR; 130-103-926, Miltenyi Biotec, Germany) and 50 ng/mL BMP4 (CYT-1093, ProSpec, Korea) for two days.

Techniques: Activation Assay

Coactivation of Wnt/BMP signaling specifies the differentiation of hiPSCs to a paraxial mesoderm. (a) A schematic diagram of the protocol of mesoderm according to the differentiation period. (b-e) Graphs of mRNA expression of MSGN1 , TBX6 , ISL1 , and NKX2.5 in mesenchymal-induced cultures (n=3). (f-g) Graphs of MSGN1 and RUNX2 mRNA expression according to the concentrations of BMP2 and BMP4 (n=3 and 5). (h-i) Graphs of TBX6 and RUNX2 mRNA expression for BMP4 (n=5). Groups: PM, Pluripotent stem cell Medium; MM, Mesoderm differentiation Medium; AC, CHIR; ACB, CHIR+BMP4. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP2, Bone morphogenetic protein 2; BMP4, Bone morphogenetic protein 4. All data represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: Coactivation of Wnt/BMP signaling specifies the differentiation of hiPSCs to a paraxial mesoderm. (a) A schematic diagram of the protocol of mesoderm according to the differentiation period. (b-e) Graphs of mRNA expression of MSGN1 , TBX6 , ISL1 , and NKX2.5 in mesenchymal-induced cultures (n=3). (f-g) Graphs of MSGN1 and RUNX2 mRNA expression according to the concentrations of BMP2 and BMP4 (n=3 and 5). (h-i) Graphs of TBX6 and RUNX2 mRNA expression for BMP4 (n=5). Groups: PM, Pluripotent stem cell Medium; MM, Mesoderm differentiation Medium; AC, CHIR; ACB, CHIR+BMP4. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP2, Bone morphogenetic protein 2; BMP4, Bone morphogenetic protein 4. All data represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Techniques: Expressing

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: Total RNA Sequencing. (a) Transcription profile of 75 genes relevant to osteogenesis for hiPSC cultured for 2 days in mesoderm differentiation medium. Relative expression: red (high) and blue (low) (b) Heatmaps for markers related to osteogenesis. Relative expression: red (high) and green (low) (c) Gene ontology enrichment dot plot. Relative expression: red (high) and big dot (high). Groups: AC, CHIR; ACB, CHIR+BMP4. hiPSC, Human induced pluripotent stem cells.

Techniques: RNA Sequencing, Cell Culture, Expressing

Limited activation of the BMP signaling in the mesoderm period promotes the maturation of osteoblasts. (a) Schematic protocol for osteoblast differentiation via mesoderm. (b) Optical images of hiPSC according to differentiation (X40). (c-d) Graphs of mRNA gene expression of RUNX2 and COL1 according to BMP4 concentration. (e-g) Graphs of mRNA expression of COL1 , ON , and OCN . ON: osteonectin, OCN: osteocalcin. Scale bar: 500 μm. Groups: DAG, Dorsal axial mesoderm; APEL, Albumin, polyvinyl alcohol, essential lipids; AC, CHIR; ACB, CHIR+BMP4. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP4, Bone morphogenetic protein 4. All data represent mean ± SD (n=5). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: Limited activation of the BMP signaling in the mesoderm period promotes the maturation of osteoblasts. (a) Schematic protocol for osteoblast differentiation via mesoderm. (b) Optical images of hiPSC according to differentiation (X40). (c-d) Graphs of mRNA gene expression of RUNX2 and COL1 according to BMP4 concentration. (e-g) Graphs of mRNA expression of COL1 , ON , and OCN . ON: osteonectin, OCN: osteocalcin. Scale bar: 500 μm. Groups: DAG, Dorsal axial mesoderm; APEL, Albumin, polyvinyl alcohol, essential lipids; AC, CHIR; ACB, CHIR+BMP4. hiPSC, Human induced pluripotent stem cells; CHIR, CHIR99021; BMP4, Bone morphogenetic protein 4. All data represent mean ± SD (n=5). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Techniques: Activation Assay, Gene Expression, Concentration Assay, Expressing

Coactivation of Wnt/BMP signaling facilitates the maturation of osteoblasts. (a) Optical images of hiPSC for 9 days with or without BMP4 (X40). (b) ARS images of hiPSC on day 9 (X40). (c) Quantification graph of ARS absorbance at 540 nm wavelength (n=4). (d) Von Kossa images of hiPSC on day 9 (X100). (e) Quantification graph of Von Kossa + area (n=6). (f) Immunofluorescence staining images for hiPSC after osteogenic differentiation (X200). (g) Quantification graph of RUNX2 + and COL1 + area (n=3). Scale bars: (a-b) 500 μm, (d) 200 μm, (f) 100 μm. Groups: AC, CHIR; ACB, CHIR+BMP4. All data represent mean ± SD. *P < 0.05, **P < 0.01, and ****P < 0.0001. The symbol * indicates comparisons with the AC group.

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: Coactivation of Wnt/BMP signaling facilitates the maturation of osteoblasts. (a) Optical images of hiPSC for 9 days with or without BMP4 (X40). (b) ARS images of hiPSC on day 9 (X40). (c) Quantification graph of ARS absorbance at 540 nm wavelength (n=4). (d) Von Kossa images of hiPSC on day 9 (X100). (e) Quantification graph of Von Kossa + area (n=6). (f) Immunofluorescence staining images for hiPSC after osteogenic differentiation (X200). (g) Quantification graph of RUNX2 + and COL1 + area (n=3). Scale bars: (a-b) 500 μm, (d) 200 μm, (f) 100 μm. Groups: AC, CHIR; ACB, CHIR+BMP4. All data represent mean ± SD. *P < 0.05, **P < 0.01, and ****P < 0.0001. The symbol * indicates comparisons with the AC group.

Techniques: Immunofluorescence, Staining

Differentiation of bone formation in vivo . (a) A schematic diagram of in vivo experiments. (b) Graph of mouse weight change. (c) Images of scaffold incubated for 6 weeks in vivo . (d) 3D rendering images for micro-CT image of scaffold. (e) Images of H&E on scaffold (X200). (f) Images of von Kossa staining on the scaffold (X200). Scale bars: (c) 50 mm, (d) 5 mm, (e-f) 100 μm. Groups: Control, no treatment; Scaffold, scaffold only; BMSC, Scaffold+BMSC; AC, Scaffold+BMSC+CHIR; ACB, Scaffold+BMSC+CHIR+BMP4. All data represent mean ± SD (n=3). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. The symbol * indicates comparisons with the Scaffold group.

Journal: Journal of Tissue Engineering

Article Title: Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction

doi: 10.1177/20417314261468879

Figure Lengend Snippet: Differentiation of bone formation in vivo . (a) A schematic diagram of in vivo experiments. (b) Graph of mouse weight change. (c) Images of scaffold incubated for 6 weeks in vivo . (d) 3D rendering images for micro-CT image of scaffold. (e) Images of H&E on scaffold (X200). (f) Images of von Kossa staining on the scaffold (X200). Scale bars: (c) 50 mm, (d) 5 mm, (e-f) 100 μm. Groups: Control, no treatment; Scaffold, scaffold only; BMSC, Scaffold+BMSC; AC, Scaffold+BMSC+CHIR; ACB, Scaffold+BMSC+CHIR+BMP4. All data represent mean ± SD (n=3). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. The symbol * indicates comparisons with the Scaffold group.

Techniques: In Vivo, Incubation, Micro-CT, Staining, Control

Review

chir99021 (MedChemExpress)

Structured Review

Images

Related Articles

other:

Passaging:

Modification:

Knock-Out:

Recombinant:

Similar Products

Image Search Results